Reckitt Benckiser: UBS maintains buy rating
(CercleFinance.com) - UBS reinstates its "buy" rating on Reckitt Benckiser shares, also maintaining its target price of 8,000 pence for them, which suggests upside potential 31% for the British health and household products group's share.
While the press suggests initial bids for its infant nutrition business, the broker believes that the sale of this business could improve Reckitt's operating margin profile, thereby ensuring that medium-term targets are met.
Copyright (c) 2022 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.